Join to View Full Profile
20 Duke Medicine CircleDurham, NC 27710
Phone+1 919-668-6688
Dr. Blobe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gerard Blobe is a highly accomplished Oncologist based in Durham, NC, with a subspeciality in Gastrointestinal Cancer. He completed his fellowship in Hematology and Medical Oncology at institutions including Brigham and Women's Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute. Dr. Blobe is currently the Associate Director of Training and Education and also holds a Professor position at Duke University Hospital. He brings expertise in treating pancreatic cancer, metastatic colon cancer, and has significant work in biomedical research, gastrointestinal oncology, and general medical oncology. Dr. Blobe has also contributed numerous publications, which have been cited multiple times in scientific journals. He has participated in clinical trials focusing on gastrointestinal cancer treatment and been honored repeatedly as one of America's Top Doctors by Castle Connolly. He was elected a member of The American Society for Clinical Investigation in 2008.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1997
Duke University School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2000 - 2026
FL State Medical License 2018 - 2020
MA State Medical License 1997 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2019
- America's Top Doctors for Cancer Castle Connolly, 2011-2019
- CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- Studying Gene Expression in Samples From Younger Patients With Neuroblastoma Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- Loss of ALK4 promotes cancer progression through regulating TGF-β receptor N-glycosylation.Manqi Zhang, Jian Chen, Mary C Leupold, Jennifer Guo, Xiangfeng Shen
Nature Communications. 2025-12-17 - 18 citationsNRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting.Swati Sharma, Marcelo Ehrlich, Manqi Zhang, Gerard C Blobe, Yoav I Henis
Communications Biology. 2024-01-19 - 2 citationsAssessing the utility of molecular diagnostic classification for cancers of unknown primary.Elle C Moore, Gerard C Blobe, Nicholas C DeVito, Brent A Hanks, Michael R Harrison
Cancer Medicine. 2023-10-01
Press Mentions
Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory BoardMarch 7th, 2022
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Grant Support
- Duke PRIME Cancer Research ProgramDUKE UNIVERSITY2023–2028
- Duke PRIME Cancer Research ProgramDUKE UNIVERSITY2023–2028
- Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education ProgramDUKE UNIVERSITY2022–2027
- Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education ProgramDUKE UNIVERSITY2022–2027
- Role of ALK4 in Regulating Receptor Trafficking and Pancreatic Cancer BiologyDUKE UNIVERSITY2019–2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
